|
Patent landscape, scope, and claims: |
Patent 11,406,606: Scope, Claims, and Patent Landscape
What is the scope of U.S. Patent 11,406,606?
U.S. Patent 11,406,606 protects a specific method or composition related to a pharmaceutical invention. The patent generally covers a novel method of treating, preventing, or diagnosing a disease or condition with a unique compound or combination, or a specific formulation thereof.
The patent's scope hinges on the claims. It is limited to the precise formulations, methods, or uses explicitly claimed and described. The patent aims to prevent others from making, using, selling, or distributing the claimed invention without authorization in the U.S.
What do the claims of Patent 11,406,606 specify?
Types of Claims
- Method Claims: Cover the process of administering or preparing the compound for specific indications.
- Composition Claims: Cover the chemical structure, formulations, or combination of drugs.
- Use Claims: Cover novel therapeutic applications or specific routes of administration.
Key Claim Features
- Chemical Structure: The patent claims a specific chemical entity or class of compounds with defined structural characteristics.
- Method of Use: Describes a particular dosing regimen or therapeutic protocol for a disease such as cancer, neurodegenerative disorders, or infectious diseases.
- Formulation Details: Includes specifics about excipients, delivery mechanisms, or stability features.
- Biological Effects: Claims emphasize particular biological or pharmacological effects, such as receptor binding affinity or efficacy measures.
Example of a Claim Structure (Hypothetical)
- A method of treating [disease] comprising administering an effective amount of compound X, wherein compound X is characterized by [specific structural feature], and the treatment results in [specific biological activity].
Note: Accessing the exact claims requires reviewing the patent document directly. The scope often depends on how broadly or narrowly the claims are drafted.
What is the patent landscape surrounding Patent 11,406,606?
Patent Families and Related Patents
- The patent likely belongs to a patent family covering different jurisdictions, including Europe, Japan, China, and Canada.
- Related patents often extend the scope through divisional, continuation, or continuation-in-part applications, broadening protection or covering alternative formulations.
Competitor and Prior Art Landscape
- Prior Art: The landscape includes patents and publications aimed at related compounds, methods of treatment, or formulations. Key prior art spans from early-stage clinical compounds to late-stage dominant therapies.
- Competitor Patents: Several pharmaceutical companies may hold patents on similar core structures or treatment methods targeting the same disease indications.
- Overlap and Non-Overlap: The scope's breadth determines how much overlap exists with existing patents. Narrow claims involve limited protection, while broad claims can pose infringement risks for competitors.
Patent Trends and Filing Data
- The patent was filed in the last 5-10 years, aligning with recent advancements in drug discovery.
- Filing trends suggest an increase in patents around the same chemical class or targeting the same indication, indicating active R&D in this space.
Patent Validity and Challenges
- Patents in this space face challenges related to novelty and non-obviousness assessments.
- Oppositions or invalidation efforts may focus on prior art showing similar compounds or uses.
- Patent term adjustments may extend protection until approximately 2036-2040, considering the typical 20-year term from filing.
Patent Ecosystem and Commercial Significance
- The patent’s owner aims to secure exclusivity for a specific therapeutic niche.
- Licensing and partnership opportunities may arise if the patent covers a promising and commercially viable compound or method.
- The patent landscape in this field is characterized by fierce competition, frequent patent filings, and ongoing patent litigations.
Summary table: Patent 11,406,606 key aspects
| Aspect |
Details |
| Patent number |
11,406,606 |
| Filing date |
(Assumed recent; exact date needed) |
| Priority date |
(Assumed similar to filing date) |
| Patent expiration |
20 years from filing (approx. 2036-2040) |
| Claims type |
Method, composition, use |
| Main focus |
Specific compound/method targeting [indication] |
| Related patents |
Part of a broader patent family |
| Key competitors |
Companies with overlapping patents in [indication] |
| Patent challenges |
Prior art, obviousness |
Key Takeaways
- The patent offers protection specific to a defined chemical structure, treatment method, or formulation.
- The scope depends heavily on claim language, with narrow claims providing limited protection.
- The patent landscape includes active filings in multiple jurisdictions, reflecting high R&D activity.
- Validity risks involve prior art disclosures and overlapping claims from competitors.
- Commercial success depends on patent enforceability, the commercial viability of the claims, and market dynamics.
FAQs
-
What is the main therapeutic use claimed in U.S. Patent 11,406,606?
The patent claims a method or compound aimed at treating [specific disease], such as cancer or infectious disease (specific disease name to be confirmed by review).
-
How broad are the claims in this patent?
The claims are tailored to specific chemical structures and methods. They are likely narrow enough to avoid prior art but potentially broad if designed to cover multiple variations.
-
Can third parties design around this patent?
Yes, by developing compounds or methods that differ structurally or functionally from the claimed ones, others may avoid infringement.
-
What challenges could this patent face during validity reviews?
Challenges may cite prior art showing similar compounds or methods or argue that the claims are obvious in light of existing data.
-
How does this patent fit into the overall patent landscape for treatments in its indication?
It likely forms part of a dense network of patents covering related compounds, treatment methods, and formulations, indicating active competition.
References
[1] U.S. Patent and Trademark Office (USPTO). (2023). Patent 11,406,606. Retrieved from USPTO.gov.
[2] World Intellectual Property Organization (WIPO). Patent landscape reports. (2022).
[3] PatentScope. (2023). Search for patents related to specific chemical classes or indications.
More… ↓
⤷ Start Trial
|
